ArticleEuropean journal of nuclear medicine and molecular imaging2019

Value proposition of PSMA-targeted α-particle radioligand therapy in metastatic prostate cancer.

Hossein JadvarPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.